Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies
US6428952B1 · kind B1 · utility
3Cited by
6References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 19, 1995 |
| Grant date | Aug 6, 2002 |
| Priority date | — |
| Expiry date | Apr 19, 2015 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/16
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Retroviruses associated with Acquired Immune Deficiency Syndrome (AIDS), including Lymphadenopathy Associated Virus (LAV), are isolated from the sera of patients afflicted with Lymphadenopathy Syndrome (LAS) or AIDS. LAV is a Human Immunodeficiency Virus (HIV). Viral extract, structural proteins and other fractions of the retrovirus immunologically recongize the sera of such patients. Immunological reaction is used to detect antibodies that specifically bind to antigenic sites of the retrovirus in samples of body fluids from patients with AIDS or risk of AIDS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.